The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2015

Filed:

Feb. 17, 2010
Applicants:

Gerd Ritter, New York, NY (US);

Anne Murray, New York, NY (US);

George Mark, New York, NY (US);

Christoph Renner, Homburg/Saar, DE;

Inventors:

Gerd Ritter, New York, NY (US);

Anne Murray, New York, NY (US);

George Mark, New York, NY (US);

Christoph Renner, Homburg/Saar, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 51/10 (2006.01); A61K 39/395 (2006.01); C07K 16/30 (2006.01); C07K 16/42 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 51/1078 (2013.01); A61K 39/39541 (2013.01); A61K 51/103 (2013.01); A61K 51/1045 (2013.01); A61K 2039/505 (2013.01); C07K 16/2863 (2013.01); C07K 16/30 (2013.01); C07K 16/4258 (2013.01); C07K 2317/24 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/77 (2013.01); C07K 2317/34 (2013.01);
Abstract

The present invention relates to specific binding members, particularly antibodies and fragments thereof, which bind to amplified epidermal growth factor receptor (EGFR) and to the de2-7 EGFR truncation of the EGFR. In particular, the epitope recognized by the specific binding members, particularly antibodies and fragments thereof, is enhanced or evident upon aberrant post-translational modification. These specific binding members are useful in the diagnosis and treatment of cancer. The binding members of the present invention may also be used in therapy in combination with chemotherapeutics or anti-cancer agents and/or with other antibodies or fragments thereof.


Find Patent Forward Citations

Loading…